Login / Signup

Effectiveness and safety of SARS-CoV-2 vaccine in Inflammatory Bowel Disease patients: a systematic review, meta-analysis and meta-regression.

Abhishek BhurwalHemant Raj MutnejaVikas BansalAkshay GoelShilpa AroraBashar AttarCarlos D MinacapelliGursimran S KochharLea Ann ChenSteve BrantDarren Seril
Published in: Alimentary pharmacology & therapeutics (2022)
In summary, the systematic review and meta-analysis suggest that SARS-CoV-2 vaccine is safe and effective in IBD patients.
Keyphrases
  • sars cov
  • end stage renal disease
  • systematic review
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • randomized controlled trial
  • respiratory syndrome coronavirus
  • meta analyses